Home Overview Press Room Blog Publications For Students about us
Search

About California Policies & Human Biotechnology


California has been a pioneer in several aspects of policy on new biotechnologies, most notably with the passage in 2004 of Proposition 71, which established the California Institute for Regenerative Medicine (CIRM) and authorized to distribute and oversee $3 billion in public funds to support stem cell research and build research facilities over ten years.

The CIRM has been closely watched by other states and countries. It launched two experiments: the first an experiment in biomedical investigation; the second in its politics and policy. Never before has a state so generously funded an emerging scientific field. And never before has a state been faced with regulating and overseeing a field that combines promising medical research with significant social risks.

Before that, the California Advisory Committee on Human Cloning issued a report that led to a state ban on reproductive cloning. In 2003, a state agency blocked the sale of genetically modified fish as pets. In 2006, the state legislature passed a law providing protections for women who may provide eggs for cloning-based stem cell research.



California Genetic Privacy Bill Moves Forward – Padilla’s SB 1267 to Protect a Person’s DNAby Valerie GottenCalifornia NewswireApril 24th, 2012California moves one step closer to passing comprehensive genetic privacy legislation, as the proposed bill clears a sub-committee hurdle.
Woman Who Ran Surrogacy Company Arrested on Fraud Chargesby Rosalio AhumadaBellingham HeraldApril 20th, 2012A California woman was arrested this week on charges that her company, SurroGenesis, was defrauding its clients.
Critics of California Stem-Cell Agency Address Institute of Medicine Panel[Quote's CGS's Marcy Darnovsky]by Erika Check HaydenNature News BlogApril 13th, 2012Speakers raised concerns about built-in conflicts of interest, oversight by elected officials, and unfulfilled promises to voters.
Statement to Institute of Medicine Committee on the California Institute for Regenerative Medicine by Marcy DarnovskyApril 10th, 2012Marcy Darnovsky of the Center for Genetics and Society made this statement before the Institute of Medicine Committee regarding CIRM's funding and governance structure.
Playing God?by Steven T. JonesSan Francisco Bay GuardianApril 3rd, 2012SynBioWatch raises concerns about the risks posed by a planned new synthetic biology lab in Richmond.
Plan to merge labs for biofuel research criticizedby David PerlmanSan Francisco ChronicleMarch 29th, 2012Synthetic biology research at a proposed facility in Richmond, California would be tied to unknown energy companies, poorly regulated, and expose employees to dangerous microbes. If successful, it would rob undeveloped nations of their croplands.
Bay Area may be at risk from synthetic biology research labsby Emily Smith BeitiksSan Jose Mercury NewsMarch 27th, 2012Lawrence Berkeley National Laboratory recently announced a proposal to build a synthetic biology lab in Richmond, which should give us pause to consider exactly what risks this little-known field poses for the environment and human health.
North Carolina Leads the Way in Compensation for Eugenic Sterilization Victimsby Emily BeitiksBiopolitical TimesMarch 22nd, 2012Will North Carolina’s efforts to compensate victims of eugenic sterilization encourage other states to follow suit?
At a Crossroads, California’s Stem Cell Agency Ponders a Future Without Taxpayer Support[Quotes CGS's Marcy Darnovsky]by Alicia ChangWashington PostMarch 18th, 2012Eight years have passed since the creation of California's stem cell agency, and the legacy CIRM will leave remains unclear.
SynBioWatch to Hold Public Discussion on Synthetic Biology Risksby Doug PetBiopolitical TimesMarch 16th, 2012A social and environmental justice coalition, SynbioWatch, will hold a public meeting to discuss the possible dangers associated with synthetic biology.
Displaying 1-10 of 607  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.625.0819 • (F) 1.510.665.8760